Quality & Outcomes: Implantable Devices
Next Generation Implantable Devices Treat Ventricular Tachycardia
Penn electrophysiologists have been at the forefront of every new development in the field of implantable devices for three decades.
The Hospital of the University of Pennsylvania (HUP) was the first in the region to use implantable devices for patients at risk for recurrent sustained VT or fibrillation and to improve cardiac function in patients with heart failure.
In August 2010, the HUP EP team implanted the region's first subcutaneous ICD (S-ICD). The new S-ICD is implanted just under the skin on the chest and eliminates the need for leads in the vascular system. Penn is also working to develop new electrical mapping and recording systems for more rapid arrhythmia diagnosis.
Device Implants at Penn Medicine CY 2007 - CY 2010, N = 7180
| Pacemakers | ICDs | |
|---|---|---|
| 2006 | 602 | 710 |
| 2007 | 668 | 718 |
| 2008 | 779 | 771 |
| 2009 | 720 | 688 |
| 2010 | 712 | 812 |
* Penn Medicine includes Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center and Pennsylvania Hospital
Penn Heart & Vascular 2011 Clinical Activity Report
Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.